Gotham Therapeutics

company

About

Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$54M
Industries
Biotechnology,Life Science,Therapeutics
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.The company offers treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$54M
Gotham Therapeutics has raised a total of $54M in funding over 2 rounds. Their latest funding was raised on Oct 10, 2018 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 10, 2018 Series A $54M 1 Versant Ventures Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Gotham Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series A